Literature DB >> 6345235

The concentration of retinoic acid determines the differentiated cell types formed by a teratocarcinoma cell line.

M K Edwards, M W McBurney.   

Abstract

Retinoic acid (RA) can induce the differentiation of teratocarcinoma cells in culture (S. Strickland and V. Mahdavi, 1978, Cell 15, 393-403; E. M. V. Jones-Villeneuve, M. W. McBurney, K. A. Rogers, and V. I. Kalnins, 1982, J. Cell. Biol. 94, 253-262). With the teratocarcinoma cell line, P19S1801A1 (O1A1), the differentiated cell types formed from cell aggregates exposed to RA are dependent on the concentration of drug used in the treatment. Cultures exposed to low concentrations (10(-9)M) are characterized by an abundance of cardiac muscle. Skeletal muscle becomes abundant at higher drug concentrations (10(-8)M) with neurons and astroglia appearing at very high concentrations (10(-7) to 10(-5) M). These results suggest that during normal embryogenesis, the commitment of pluripotent cells to particular developmental avenues may be determined in part by concentration gradients of substances such as retinoids.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345235     DOI: 10.1016/0012-1606(83)90348-2

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  48 in total

1.  Menin induces endodermal differentiation in aggregated P19 stem cells by modulating the retinoic acid receptors.

Authors:  Jyotshnabala Kanungo; Settara C Chandrasekharappa
Journal:  Mol Cell Biochem       Date:  2011-08-11       Impact factor: 3.396

2.  The avian retrovirus env gene family: molecular analysis of host range and antigenic variants.

Authors:  C A Bova; J C Olsen; R Swanstrom
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

3.  The Wnt-1 (int-1) oncogene promoter and its mechanism of activation by insertion of proviral DNA of the mouse mammary tumor virus.

Authors:  R Nusse; H Theunissen; E Wagenaar; F Rijsewijk; A Gennissen; A Otte; E Schuuring; A van Ooyen
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

4.  Localization of the cellular retinoic acid binding protein (CRABP) gene relative to the acute promyelocytic leukemia-associated breakpoint on human chromosome 15.

Authors:  A Geurts van Kessel; H de Leeuw; E J Dekker; L Rijks; N Spurr; D Ledbetter; E Kootwijk; M J Vaessen
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

5.  A novel cis-acting DNA element required for a high level of inducible expression of the rat P-450c gene.

Authors:  A Yanagida; K Sogawa; K I Yasumoto; Y Fujii-Kuriyama
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

6.  Tissue inhibitor of metalloproteinase-2 (TIMP-2) expression is regulated by multiple neural differentiation signals.

Authors:  Diane M Jaworski; Leonor Pérez-Martínez
Journal:  J Neurochem       Date:  2006-07       Impact factor: 5.372

7.  Identification and characterization of the CDK12/cyclin L1 complex involved in alternative splicing regulation.

Authors:  Hung-Hsi Chen; Yu-Chiuan Wang; Ming-Ji Fann
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Oxytocin in cardiac ontogeny.

Authors:  Marek Jankowski; Bogdan Danalache; Donghao Wang; Pangala Bhat; Fadi Hajjar; Mieczyslaw Marcinkiewicz; Joanne Paquin; Samuel M McCann; Jolanta Gutkowska
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-17       Impact factor: 11.205

9.  A cyclic AMP response element is involved in retinoic acid-dependent RAR beta 2 promoter activation.

Authors:  F A Kruyt; G Folkers; C E van den Brink; P T van der Saag
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

10.  Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin.

Authors:  Karen A M Kennedy; Tammy Porter; Virja Mehta; Scott D Ryan; Feodor Price; Vian Peshdary; Christina Karamboulas; Josée Savage; Thomas A Drysdale; Shun-Cheng Li; Steffany A L Bennett; Ilona S Skerjanc
Journal:  BMC Biol       Date:  2009-10-08       Impact factor: 7.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.